135 results
Page 4 of 7
8-K
EX-99.2
re4399gl8vl3go5
6 Jul 20
Our mission is to create a world without infectious disease
6:32am
DRS
EX-10.55
o5au8sihle r94vw1q
23 Jun 20
Draft registration statement
12:00am
DRS
EX-10.58
cfn645814o2eqj
23 Jun 20
Draft registration statement
12:00am
DRS
EX-10.53
dh6jiq bgts9omvvx
23 Jun 20
Draft registration statement
12:00am
DRS
EX-10.54
rfxwppmh7i7nr a9
23 Jun 20
Draft registration statement
12:00am
8-K
EX-99.1
e7rt iied9
19 Jun 20
Patent License Agreement
5:26pm
8-K
EX-99.1
wdc1xmq bl1opvusj4bk
29 May 20
Vir Biotechnology and Biogen Execute Agreement to ManufactureSARS-CoV-2 Antibodies for PotentialCOVID-19 Treatment
4:06pm
D
8qhr0
8 May 20
$32.44M in equity, sold $32.44M, 1 investor
4:04pm
D
f9xhhw4 hk
8 May 20
$250M in equity, sold $250M, 1 investor
4:01pm
DEF 14A
3qbqsvh
6 Apr 20
Definitive proxy
4:52pm
10-K
8u5j2byba01
26 Mar 20
Annual report
4:08pm
10-Q
ahcww6 gwqt
19 Nov 19
Quarterly report
4:06pm
8-K
EX-3.2
vex5d zmk874
16 Oct 19
Departure of Directors or Certain Officers
4:01pm
S-8
EX-4.11
30j0t4400tb0ojmetfy
15 Oct 19
Registration of securities for employees
4:47pm
S-8
EX-4.8
c7s4zdl
15 Oct 19
Registration of securities for employees
4:47pm
424B4
nr14 21m7b9kuz7h
11 Oct 19
Prospectus supplement with pricing info
5:31pm
S-1/A
EX-3.1
9fk3m90x
30 Sep 19
IPO registration (amended)
6:12am
S-1/A
EX-10.7
drwotd146
30 Sep 19
IPO registration (amended)
6:12am
S-1/A
EX-1.1
9gb8xo 98l9j6eo
30 Sep 19
IPO registration (amended)
6:12am